Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition:   Primary Biliary CirrhosisInterventions:   Biological: NGM282;   Biological: PlaceboSponsors:   NGM Biopharmaceuticals, Inc;   NGM Biopharmaceuticals Australia Pty LtdNot yet recruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2013 Category: Research Source Type: clinical trials

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition:   Primary Biliary CirrhosisInterventions:   Biological: NGM282;   Biological: PlaceboSponsors:   NGM Biopharmaceuticals, Inc;   NGM Biopharmaceuticals Australia Pty LtdRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2013 Category: Research Source Type: clinical trials